Retreatment

• 

  Subject Areas on Research

  • A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses. 
  • A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13. 
  • A comparison of débridement with and without anconeus muscle flap for treatment of refractory lateral epicondylitis. 
  • A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapy. 
  • A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation. 
  • A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study. 
  • ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. 
  • AGA Technical Review on Systemic Therapies for Hepatocellular Carcinoma. 
  • Acceptance of repeat esophagogastroduodenoscopy to detect gastric cancer in a Chinese immigrant cohort. 
  • American Society of Radiation Oncology recommendations for documenting intensity-modulated radiation therapy treatments. 
  • Analysis of outcomes following failed endovascular treatment of chronic limb ischemia. 
  • Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174? 
  • Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar. 
  • Arterial reconstructions for pediatric splanchnic artery occlusive disease. 
  • Arteriovenous Graft Delamination and Dissection as a Cause of Graft Dysfunction. 
  • Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study. 
  • Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma. 
  • Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology. 
  • Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma. 
  • Clinical characteristics associated with poor long-term survival among patients with diabetes mellitus undergoing saphenous vein graft interventions. 
  • Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. 
  • Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: a report from the National Cardiovascular Data Registry. 
  • Comparison of above- and below-elbow casting for pediatric distal metaphyseal forearm fractures. 
  • Comparison of medicine alone, coronary angioplasty, and left internal mammary artery-coronary artery bypass for one-vessel proximal left anterior descending coronary artery disease. 
  • Complete longitudinal analyses of the randomized, placebo-controlled, phase III trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failure. 
  • Complete revascularisation in ST-elevation myocardial infarction and multivessel disease: meta-analysis of randomised controlled trials. 
  • Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions. 
  • Defining success after surgery for pelvic organ prolapse. 
  • Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study. 
  • Diagnosing coronary arterial stent thrombosis and arterial closure. 
  • Discontinuing mechanical ventilatory support: removing positive pressure ventilation vs removing the artificial airway. 
  • Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: results from the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. 
  • Effectiveness and Downstream Healthcare Utilization for Patients That Received Early Physical Therapy Versus Usual Care for Low Back Pain: A Randomized Clinical Trial. 
  • Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study. 
  • Evolving practice pattern changes and outcomes in the era of hybrid aortic arch repair. 
  • Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis. 
  • Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect MM Registry (2010-2016). 
  • Hybrid Surgery for Internal Carotid Artery Revascularization. 
  • Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial. 
  • Imaging-guided percutaneous thrombin injection for the treatment of iatrogenic femoral artery pseudoaneurysms. 
  • Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: acute and six month outcomes. 
  • Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. 
  • Laser in infrapopliteal and popliteal stenosis 2 study (LIPS2): Long-term outcomes of laser-assisted balloon angioplasty versus balloon angioplasty for below knee peripheral arterial disease. 
  • Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series. 
  • Matched Comparison of Flow Diversion and Coiling in Small, Noncomplex Intracranial Aneurysms. 
  • NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017. 
  • NCCN Guidelines Insights: Melanoma, Version 3.2016. 
  • Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. 
  • Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma. 
  • Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials. 
  • Patient-preferred sites of restylane injection in periocular and facial soft-tissue augmentation. 
  • Pelvic Floor Disorders Registry: Study Design and Outcome Measures. 
  • Percutaneous repair or surgery for mitral regurgitation. 
  • Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. 
  • Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma. 
  • Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitor. 
  • Phase I/II study of the novel proteasome inhibitor delanzomib (CEP-18770) for relapsed and refractory multiple myeloma. 
  • Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy. 
  • Pipeline Embolization Device in the Treatment of Recurrent Previously Stented Cerebral Aneurysms. 
  • Pipeline-assisted coiling versus pipeline in flow diversion treatment of intracranial aneurysms. 
  • Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema. 
  • Platelet inhibition with cangrelor in patients undergoing PCI. 
  • Predictors of reintubation in critically ill patients. 
  • Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation. 
  • Protocolized Post-Extubation Respiratory Support to prevent reintubation: protocol and statistical analysis plan for a clinical trial. 
  • Pulmonary stenting for the treatment of sarcoid induced pulmonary vascular stenosis. 
  • Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality. 
  • RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. 
  • Radiation dose-volume effects in the spinal cord. 
  • Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. 
  • Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis. 
  • Reinterventions in the superficial femoral artery. 
  • Reirradiation for recurrent head and neck cancer. 
  • Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention. 
  • Remedial operations for failed endovascular therapy of 32 renal artery stenoses in 24 children. 
  • Reoperation for prolapse recurrence after sacrospinous mesh hysteropexy: characteristics of women choosing retreatment. 
  • Repeat neuroimaging of mild traumatic brain-injured patients with acute traumatic intracranial hemorrhage: clinical outcomes and radiographic features. 
  • Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year. 
  • Results of a 5-year multicenter trial of a new generation cooled high energy transurethral microwave thermal therapy catheter for benign prostatic hyperplasia. 
  • Retreatment with talimogene laherparepvec for advanced melanoma. 
  • Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response. 
  • Rising PSA Level in an Anxious Postprostatectomy Patient. 
  • Risk-benefit trade-offs in revascularisation choices. 
  • Routine postoperative imaging is important after ureteroscopic stone manipulation. 
  • SCORE Study report 3: study design and baseline characteristics. 
  • Segment Length in Cine Strain Analysis Predicts Cardiac Resynchronization Therapy Outcome Beyond Current Guidelines. 
  • Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. 
  • Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study. 
  • Simultaneous restenosis of Taxus and Cypher drug-eluting stents. 
  • Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease. 
  • Six-month outcomes of percutaneous coronary balloon angioplasty in acute coronary syndromes: Results from the PURSUIT trial. 
  • Stress imaging use and repeat revascularization among medicare patients with high-risk coronary artery disease. 
  • Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort. 
  • Success and failure are dynamic, recurrent event states after surgical treatment for pelvic organ prolapse. 
  • Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients. 
  • Technical innovation. Using a cutting balloon to treat resistant high-grade dialysis graft stenosis. 
  • Techniques and benefits of multiple internal mammary artery bypass at 20 years of follow-up. 
  • Telaprevir for previously treated chronic HCV infection. 
  • Temporal trends in percutaneous coronary intervention outcomes among older patients in the United States. 
  • The Association of Previous Revascularization With In-Hospital Outcomes in Acute Myocardial Infarction Patients: Results From the National Cardiovascular Data Registry. 
  • The Effect of Clinical Care Location on Clinical Outcomes After Peripheral Vascular Intervention in Medicare Beneficiaries. 
  • The Use of Re-irradiation in Locally Recurrent, Non-metastatic Rectal Cancer. 
  • The Use of the Pipeline Embolization Device in the Management of Recurrent Previously Coiled Cerebral Aneurysms. 
  • The natural history of type II endoleaks after endovascular aneurysm repair for ruptured abdominal aortic aneurysm. 
  • The truth and consequences of the COURAGE trial. 
  • Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032. 
  • Toward individualized post-electroconvulsive therapy care: piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention. 
  • Training, detraining, and retraining: Two 12-week respiratory muscle training regimens in a child with infantile-onset Pompe disease. 
  • Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. 
  • Transplantation outcomes for severe combined immunodeficiency, 2000-2009. 
  • Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial. 
  • Treatment of central venous in-stent restenosis with repeat stent deployment in hemodialysis patients. 
  • Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange. 
  • Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections. 
  • Treatment selection in metastatic renal cell carcinoma: more confusion or a path forward? 
  • Trends in age-related macular degeneration management in Singapore. 
  • Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study. 
  • Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. 
  • Updated Results of Rituximab Pre- and Post-BEAM with or without 90Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma. 
  • Use of an Electronic Medical Record to Assess Patient-Reported Morbidity Following Ureteroscopy. 
  • Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial. 
  • Use of stress testing and diagnostic catheterization after coronary stenting: association of site-level patterns with patient characteristics and outcomes in 247,052 Medicare beneficiaries. 
  • Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. 
  • Vorapaxar in the secondary prevention of atherothrombotic events. 
  • White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry). 
• 

  Keywords of People

  • Brennan, J. Matthew, Associate Professor of Medicine, Medicine, Cardiology
  • Buckley, Rebecca Hatcher, James Buren Sidbury Distinguished Professor Emeritus of Pediatrics, in the School of Medicine, Pediatrics, Allergy and Immunology
  • Fekrat, Sharon, Professor of Ophthalmology, Ophthalmology, Vitreoretinal Diseases & Surgery
  • Mithani, Suhail Kamrudin, Associate Professor of Surgery, Surgery, Plastic, Maxillofacial, and Oral Surgery
  • Preminger, Glenn Michael, James F. Glenn, M.D. Distinguished Professor of Urology, Surgery, Urology
  • Woodward, Julie Ann, Professor of Ophthalmology, Dermatology